On December 17, 2021 TRANSGENE (Paris:TNG) reported that Management will participate in the upcoming investor events set out below (Press release, Transgene, DEC 17, 2021, View Source [SID1234597379]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Transgene will meet institutional investors at the 11th Annual LifeSci Advisors Corporate Access Event (virtual event) from January 5th to 7th, 2022.

The Company will also attend:

25th ODDO BHF Digital Forum (virtual): January 6, 7, 10 and 11, 2022
Biotech Showcase Investor Conference (virtual):
January 10 to 12, 2022, in conjunction with the J.P. Morgan Healthcare conference
January 17 to 19, 2022
Biomed Event (Paris): January 26, 2022